Abstract:There is no pharmacological treatment available to limit progressing neuronal death after cerebral ischemia. Here we show that targeting the interaction of GABAB receptors with CaMKII using a synthetic interfering peptide after an excitotoxic insult in cultured neurons or in brain slices from MCAO‐treated mice restored downregulated GABAB receptor expression and function, normalized aberrant expression of their major effectors, reduced neuronal excitability, activated the Akt survival pathway, and inhibited progressing neuronal death. Cerebral ischemia is the leading cause for long‐term disability and mortality in adults due to massive neuronal death. Currently, there is no pharmacological treatment available to limit progressive neuronal death after stroke. A major mechanism causing ischemia‐induced neuronal death is the excessive release of glutamate and the associated overexcitation of neurons (excitotoxicity). Normally, GABAB receptors control neuronal excitability in the brain via prolonged inhibition. However, excitotoxic conditions rapidly downregulate GABAB receptors via a CaMKII‐mediated mechanism and thereby diminish adequate inhibition that could counteract neuronal overexcitation and neuronal death. To prevent the deleterious downregulation of GABAB receptors, we developed a cell‐penetrating synthetic peptide (R1‐Pep) that inhibits the interaction of GABAB receptors with CaMKII. Administration of this peptide to cultured cortical neurons exposed to excitotoxic conditions restored cell surface expression and function of GABAB receptors. R1‐Pep did not affect CaMKII expression or activity but prevented its T286 autophosphorylation that renders it autonomously and persistently active. Moreover, R1‐Pep counteracted the aberrant downregulation of G protein‐coupled inwardly rectifying K+ channels and the upregulation of N‐type voltage‐gated Ca2+ channels, the main effectors of GABAB receptors. The restoration of GABAB receptors activated the Akt survival pathway and inhibited excitotoxic neuronal death with a wide time window in cultured neurons. Restoration of GABAB receptors and neuroprotective activity of R1‐Pep was verified by using brain slices prepared from mice after middle cerebral artery occlusion (MCAO). Treatment with R1‐Pep restored normal GABAB receptor expression and GABA receptor‐mediated K+ channel currents. This reduced MCAO‐induced neuronal excitability and inhibited neuronal death. These results support the hypothesis that restoration of GABAB receptor expression under excitatory conditions provides neuroprotection and might be the basis for the development of a selective intervention to inhibit progressive neuronal death after ischemic stroke.

Neuronal Protection by Ha-RAS-GTPase Signaling through Selective Downregulation of Plasmalemmal Voltage-Dependent Anion Channel-1

Specific Disruption of Astrocytic Ca2+ Signaling Pathway in Vivo by Adeno-Associated Viral Transduction.

Targeting the interaction of GABAB receptors with CaMKII with an interfering peptide restores receptor expression after cerebral ischemia and inhibits progressive neuronal death in mouse brain cells and slices

Neuroprotective Mitochondrial Remodeling by AKAP121/PKA Protects HT22 Cell from Glutamate-Induced Oxidative Stress.

Voltage-dependent anion channels (VDACs) promote mitophagy to protect neuron from death in an early brain injury following a subarachnoid hemorrhage in rats.

VDAC1 regulates neuronal cell loss after retinal trauma injury by a mitochondria-independent pathway

Voltage‐dependent Anion Channel Promotes Mitophagy to Protect Neuron from Death in an Early Brain Injury Following a Subarachnoid Hemorrhage in Rats (730.1)

N-methyl-d-aspartate Receptor-mediated Preconditioning Mitigates Excitotoxicity in Human Induced Pluripotent Stem Cell-derived Brain Organoids

The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons

Abstract 2473: Ubiquitin Ligase Huwe1 Modulates Prongf/p75ntr in Monkey Cerebral Ischemia-reperfusion Injury

Neuronal Rho GTPase Rac1 elimination confers neuroprotection in a mouse model of permanent ischemic stroke

Neuronal RARβ Signaling Modulates PTEN Activity Directly in Neurons and via Exosome Transfer in Astrocytes to Prevent Glial Scar Formation and Induce Spinal Cord Regeneration

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

Microglial reprogramming by Hv1 antagonism protects neurons from inflammatory and glutamate toxicity

Proteinase-Activated Type 1 Receptors are Involved in the Mechanism of Protection of Rat Hippocampal Neurons from Glutamate Toxicity

Neuroprotection Against Neonatal Hypoxia/ischemia-Induced Cerebral Cell Death by Prevention of Calpain-Mediated Mglur1α Truncation

Targeting Cellular Retinoic Acid Binding Protein 1 with Retinoic Acid-like Compounds to Mitigate Motor Neuron Degeneration

RhoA as a target to promote neuronal survival and axon regeneration

Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences.

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

Tissue-type Plasminogen Activator Protects Neurons from Excitotoxin-Induced Cell Death Via Activation of the ERK 1/2–CREB–ATF3 Signaling Pathway